Dr Jake Powrie's Publications s4

Total Page:16

File Type:pdf, Size:1020Kb

Dr Jake Powrie's Publications s4

Professor Richard Beale’s publications

1. Physiological predictors of survival during high-frequency oscillatory ventilation in adults with acute respiratory distress syndrome. Camporota L, Sherry T, Smith J, Lei K, McLuckie A, Beale R. Crit Care. 2013 Mar 4;17(2):R40.

2. Retrospective analysis of outcome of women with breast or gynaecological cancer in the intensive care unit. Ostermann M, Raimundo M, Williams A, Whiteley C, Beale R. JRSM Short Rep. 2013 Jan;4(1):2.

3. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb SA, Beale RJ, Vincent JL, Moreno R; Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup. Crit Care Med. 2013;41:580- 637.

4. Acute Respiratory Distress Syndrome; The Berlin Definition. The ARDS Definition Task Force. JAMA 2013;307: 2526-33

5. Reinhart K, Perner A, Sprung CL, Jaeschke R, Schortgen F, Johan Groeneveld AB, Beale R, Hartog CS. Consensus statement of the ESICM task force on colloid volume therapy in critically ill patients. Intensive Care Med. 2012;38(3):368-83.

6. Global utilization of low-dose corticosteroids in severe sepsis and septic shock: a report from the PROGRESS registry. Beale R, Janes JM, Brunkhorst FM, Dobb G, Levy MM, Martin GS, Ramsay G, Silva E, Sprung CL, Vallet B, Vincent JL, Costigan TM, Leishman AG, Williams MD, Reinhart K. Crit Care. 2010 Jun 3;14(3):R102.

7. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Levy MM, Dellinger RP, Townsend SR, Linde-Zwirble WT, Marshall JC, Bion J, Schorr C, Artigas A, Ramsay G, Beale R, Parker MM, Gerlach H, Reinhart K, Silva E, Harvey M, Regan S, Angus DC; Surviving Sepsis Campaign. Crit Care Med. 2010 Feb;38(2):367-74.

8. Kesecioglu J, Beale R, Stewart TE, Findlay GP, Rouby JJ, Holzapfel L, Bruins P, Steenken EJ, Jeppesen OK, Lachmann B. Exogenous Natural Surfactant for Treatment of Acute Lung Injury and the Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2009 Aug 27. [Epub ahead of print]

9. Beale R, Reinhart K, Brunkhorst FM, Dobb G, Levy M, Martin G, Martin C, Ramsey G, Silva E, Vallet B, Vincent JL, Janes JM, Sarwat S, Williams MD; PROGRESS Advisory Board. Promoting Global Research Excellence in Severe Sepsis (PROGRESS): lessons from an international sepsis registry. Infection. 2009 Jun;37(3):222-32. Epub 2009 Apr 28.

1 of 6 10. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun- Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL; International Surviving Sepsis Campaign Guidelines Committee; American Association of Critical-Care Nurses; American College of Chest Physicians; American College of Emergency Physicians; Canadian Critical Care Society; European Society of Clinical Microbiology and Infectious Diseases; European Society of Intensive Care Medicine; European Respiratory Society; International Sepsis Forum; Japanese Association for Acute Medicine; Japanese Society of Intensive Care Medicine; Society of Critical Care Medicine; Society of Hospital Medicine; Surgical Infection Society; World Federation of Societies of Intensive and Critical Care Medicine. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008 Jan;36(1):296-327

11. Beale RJ, Sherry T, Lei K, Campbell-Stephen L, McCook J, Smith J, Venetz W, Alteheld B, Stehle P, Schneider H. Early enteral supplementation with key pharmaconutrients improves Sequential Organ Failure Assessment score in critically ill patients with sepsis: outcome of a randomized, controlled, double-blind trial. Crit Care Med. 2008 Jan;36(1):131-44.

12. Vincent JL, Bernard GR, Beale R, Doig C, Putensen C, Dhainaut JF, Artigas A, Fumagalli R, Macias W, Wright T, Wong K, Sundin DP, Turlo MA, Janes J. Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: further evidence for survival and safety and implications for early treatment. Crit Care Med. 2005 Oct;33(10):2266-77.

13. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Levy MM, Dellinger RP, Townsend SR, Linde-Zwirble WT, Marshall JC, Bion J, Schorr C, Artigas A, Ramsay G, Beale R, Parker MM, Gerlach H, Reinhart K, Silva E, Harvey M, Regan S, Angus DC. Intensive Care Med. 2010 Feb;36(2):222-31. Epub 2010 Jan 13.

14. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Levy MM, Dellinger RP, Townsend SR, Linde-Zwirble WT, Marshall JC, Bion J, Schorr C, Artigas A, Ramsay G, Beale R, Parker MM, Gerlach H, Reinhart K, Silva E, Harvey M, Regan S, Angus DC; Surviving Sepsis Campaign. Crit Care Med. 2010 Feb;38(2):367-74.

15. The Metabolic Effects of Intensive Insulin Therapy in Critically Ill Patients. Whyte M, Jackson N, Shojaee-Moradie F, Treacher D, Beale R, Jones R, Umpleby M. Am J Physiol Endocrinol Metab. 2009 Dec 22. [Epub ahead of print]

16. Kesecioglu J, Beale R, Stewart TE, Findlay GP, Rouby JJ, Holzapfel L, Bruins P, Steenken EJ, Jeppesen OK, Lachmann B. Exogenous Natural Surfactant for Treatment of Acute Lung Injury and the Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2009 Aug 27

17. Beale RJ, Reinhart K, Brunkhorst FM, Dobb G, Levy M, Martin G, Martin C, Ramsey G, Silva E, Vallet B, Vincent J-L, Janes JM, Sarwat S, Williams MD. Promoting Global Research Excellence in Severe Sepsis (PROGRESS): Lessons from an International Sepsis Registry. Infection A journal of Infectious Disease June 2009; 37 (3) 222-232

2 of 6 18. Martin G, Brunkhorst FM, Janes JM, Reinhart K, Sundin DP, Garnett K, Beale R. The international PROGRESS registry of patients with severe sepsis: drotrecogin alfa (activated) use and patient outcomes. Crit Care. 2009;13(3):R103. Epub 2009 Jun 30

19. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun- Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL; International Surviving Sepsis Campaign Guidelines Committee; American Association of Critical-Care Nurses; American College of Chest Physicians; American College of Emergency Physicians; Canadian Critical Care Society; European Society of Clinical Microbiology and Infectious Diseases; European Society of Intensive Care Medicine; European Respiratory Society; International Sepsis Forum; Japanese Association for Acute Medicine; Japanese Society of Intensive Care Medicine; Society of Critical Care Medicine; Society of Hospital Medicine; Surgical Infection Society; World Federation of Societies of Intensive and Critical Care Medicine. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008 Jan;36(1):296-327. Erratum in: Crit Care Med. 2008 Apr;36(4):1394-6.

20. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun- Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med. 2008 Jan;34(1):17-60.

21. Beale RJ, Sherry T, Lei K, Campbell-Stephen L, McCook J, Smith J,Venetz W, Alteheld B, Stehle P, Schneider H. Early enteral supplementation with key pharmaconutrients improves Sequential Organ Failure Assessment score in critically ill patients with sepsis: outcome of a randomized, Controlled, double-blind trial. Crit Care Med.2008 Jan;36(1):131-44.

22. Camporota L, Corno E, Menaldo E, Smith J, Lei K, Beale R, Wyncoll D. Filter survival time and requirement of blood products in patients with severe sepsis receiving drotrecogin alfa (activated) and requiring renal replacement therapy. Crit Care. 2008;12(6):R163. Epub 2008 Dec 18

23. Edgeworth JD, Yadegarfar G, Pathak S, Batra R, Cockfield JD, Wyncoll D, Beale R, Lindsay JA. An outbreak in an intensive care unit of a strain of methicillin-resistant Staphylococcus aureus sequence type 239 associated with an increased rate of vascular access device-related bacteremia. Clin Infect Dis. 2007 Feb 15;44(4):493-501.

24. Z'Graggen WJ, Lin CS, Howard RS, Beale RJ, Bostock H. Nerve excitability changes in critical illness polyneuropathy. Brain. 2006 Sep;129(Pt 9):2461-70.

25. Jones A, Webb I, Gibbs T, Beale R. Discordant response to ACTH stimulation in patients with septic shock. Intensive Care Med. 2006 Sep;32(9):1440-1.

26. O'Callaghan G, Beale RJ. The role of immune-enhancing diets in the management of perioperative patients. Crit Care Resusc. 2003 Dec;5(4):277-83.

3 of 6 27. Vincent JL, Bernard GR, Beale R, Doig C, Putensen C, Dhainaut JF, Artigas A, Fumagalli R, Macias W, Wright T, Wong K, Sundin DP, Turlo MA, Janes J. Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: further evidence for survival and safety and implications for early treatment. Crit Care Med. 2005 Oct;33(10):2266-77.

28. Bollen CW, van Well GT, Sherry T, Beale RJ, Shah S, Findlay G, Monchi M, Chiche JD, Weiler N, Uiterwaal CS, van Vught AJ. High frequency oscillatory ventilation compared with conventional mechanical ventilation in adult respiratory distress syndrome: a randomized controlled trial Crit Care. 2005 Aug;9(4):R430-9.

29. Nathens AB, Curtis JR, Beale RJ, Cook DJ, Moreno RP, Romand JA, Skerrett SJ, Stapleton RD, Ware LB, Waldmann CS. Management of the critically ill patient with severe acute pancreatitis. Crit Care Med. 2004 Dec;32(12):2524-36.

30. Beale RJ, Hollenberg SM, Vincent JL, Parrillo JE. Vasopressor and inotropic support in septic shock: an evidence-based review. Crit Care Med. 2004 Nov;32(11 Suppl):S455-65.

31. Reinhart K, Meier-Hellmann A, Beale R, Forst H, Boehm D, Willatts S, Rothe KF, Adolph M, Hoffmann JE, Boehme M, Bredle DL; EASy-Study Group. Open randomized phase II trial of an extracorporeal endotoxin adsorber in suspected Gram-negative sepsis. Crit Care Med. 2004Aug;32(8):1662-8.

32. Abraham E, Reinhart K, Opal S, Demeyer I, Doig C, Rodriguez AL, Beale R, Svoboda P, Laterre PF, Simon S, Light B, Spapen H, Stone J, Seibert A, Peckelsen C, De Deyne C, Postier R, Pettila V, Artigas A, Percell SR, Shu V, Zwingelstein C, Tobias J, Poole L, Stolzenbach JC, Creasey AA; OPTIMIST Trial Study Group. Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial.JAMA.2003Jul9;290(2):238-47.

33. Dargan PI, Giles LJ, Wallace CI, House IM, Thomson AH, Beale RJ, Jones AL. Case report: severe mercuric sulphate poisoning treated with 2,3-dimercaptopropane-1-sulphonate and haemodiafiltration. Crit Care. 2003 Jun;7(3):R1-6.

34. Honore PM, Jacquet LM, Beale RJ, Renauld JC, Valadi D, Noirhomme P, Goenen M. Effects of normothermia versus hypothermia on extravascular lung water and serum cytokines during cardiopulmonary bypass: a randomized, controlled trial. Crit Care Med. 2001 ct;29(10):1903-9.

35. Daly K, Beale R, Chang RW. Reduction in mortality after inappropriate early discharge from intensive care unit: logistic regression triage model.BMJ.2001.May26;322(7297):1274-6.

36. Wyncoll D, Beale R. Immunologically enhanced enteral nutrition: current status. Curr Opin Crit Care. 2001 Apr;7(2):128-32.

37. Giles LJ, Jennings AC, Thomson AH, Creed G, Beale RJ, McLuckie A. Pharmacokinetics of meropenem in intensive care unit patients receiving continuous veno-venous hemofiltration or hemodiafiltration. CritCareMed.2000Mar;28(3):632-7.

4 of 6 38. Boyle NH, Roberts PC, Ng B, Berkenstadt H, McLuckie A, Beale RJ, Mason RC. Scanning laser Doppler is a useful technique to assess foot cutaneous perfusion during femoral artery cannulation. Crit Care. 1999;3(4):95-100.

39. Jacquet L, Honore P, Beale R, Valadi D, Dion R, Goenen M. Cardiac function after intermittent antegrade warm blood cardioplegia: contribution of the double-indicator dilution technique. Intensive Care Med.2000Jun;26(6):686-92.

40. Sakka SG, Ruhl CC, Pfeiffer UJ, Beale R, McLuckie A, Reinhart K, Meier-Hellmann A. Assessment of cardiac preload and extravascular lung water by single transpulmonary thermodilution. Intensive Care Med.2000Feb;26(2):180-7.

41. Beale RJ, Bryg DJ, Bihari DJ. Immunonutrition in the critically ill: a systematic review of clinical outcome. Crit Care Med. 1999 Dec;27(12):2799-805.

42. Sandison AJ, Wyncoll DL, Edmondson RC, Van Heerden N, Beale RJ, Taylor PR. ICU protocol may affect the outcome of non-elective abdominal aortic aneurysm repair. Eur J Vasc Endovasc Surg. 1998 Oct;16(4):356-61.

43. Newman PJ, Quinn AC, Grounds RM, Hunter JM, Boyd AH, Eastwood NB, Pollard BJ, Pearson AJ, Harper NJ, Beale RJ, Sutjarittam M, Elliot JM, Bion JF. A comparison of cisatracurium (51W89) and atracurium by infusion in critically ill patients. Crit Care Med. 1997 Jul;25(7):1139-42.

44. Wyncoll DL, Roberts PC, Beale RJ, McLuckie A.H2 blockers in the intensive care unit: ignoring the evidence? Telephone survey. BMJ. 1997 Apr 5;314(7086):1013.

45. Maynard ND, Bihari DJ, Dalton RN, Beale R, Smithies MN, Mason RC.Liver function and splanchnic ischemia in critically ill patients. Chest. 1997Jan;111(1):180-7.

46. Lichtwarck-Aschoff M, Beale R, Pfeiffer UJ.Central venous pressure, pulmonary artery occlusion pressure, intrathoracic blood volume, and right ventricular end-diastolic volume as indicators of cardiac preload. J CritCare.1996Dec;11(4):180-8.

47. Beale R. VO2 and DO2 during cardiogenic shock and infection. Anasthesiol Intensivmed Notfallmed Schmerzther. 1996 May;31(1 Suppl):S22-5. Review.

48. Stuart LM, Rice PS, Lloyd G, Beale RJ. A soldier in respiratory distress. Lancet. 1996 Jan 6;347(8993):30.

49. Grover ER, Beale R, Smithies M, Bihari D. Nitric oxide and ARDS. Anaesth Intensive Care. 1994 Jun;22(3):312-3.

50. Smithies M, Yee TH, Jackson L, Beale R, Bihari D. Protecting the gut and the liver in the critically ill: effects of dopexamine. Crit Care Med. 1994May;22(5):789-95.

5 of 6 51. Beale R, Grover ER, Smithies M, Bihari D. Acute respiratory distress syndrome ("ARDS"): no more than a severe acute lung injury? BMJ. 1993 Nov 20;307(6915):1335-9.

52. Maynard N, Bihari D, Beale R, Smithies M, Baldock G, Mason R, McCollI.Assessment of splanchnic oxygenation by gastric tonometry in patients with acute circulatory failure. JAMA. 1993 Sep 8;270(10):1203-10.

53. Fairfield JE, Dritsas A, Beale RJ. Haemodynamic effects of propofol: induction with 2.5 mg kg-1. Br J Anaesth. 1991 Nov;67(5):618-20.

Editorials

1. Gardner RM, Beale RJ Pressure to perform: is cardiac output estimation from arterial waveforms good enough for routine use? Crit Care Med. 2009 Jan;37(1):337-8. 2. Beale R. Echoes of the past? Crit Care Med. 2008 Jun;36(6):1950-1.

3. Beale R. Are we ready for MEDS in the ED? Crit Care Med. 2007 Jan;35(1):318-9. Multiple organ failure: the pilgrim's progress. Beale R, Bihari D. Crit Care Med. 1993 Feb;21(2 Suppl):S1-3.

6 of 6

Recommended publications